Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by happyretirementon Mar 03, 2017 2:11pm
127 Views
Post# 25928537

RE:Concordia International (T.CXR) Time to Watch It

RE:Concordia International (T.CXR) Time to Watch ItCan one of the Einstein boys possibly explain to me how the CMA is going to prove that from Jan. 1st 2013 until October 20th 2015 that Concordia had anything to do with either Amdipharm or Cinven legally in reference to Hydrocortisone tablets.....thanks in advance, this should be a beauty...

The statement of objections is additionally addressed to Cinven as the ultimate parent
company of Concordia International (Jersey) Limited from 1 January 2013 until 20 October 2015, and Concordia International Corporation from 21 October 2015 until 24 June 2016

The CMA proposes to find that the undertaking referred to in this press notice as
‘Concordia’ consists of the following legal entities:
  • From 1 January 2013 until 20 October 2015:
    • Amdipharm Limited
    • Concordia International Rx (UK) Limited (Concordia Rx) (formerly known as Amdipharm Mercury Company Limited)
    • Concordia International (Jersey) Limited (formerly known as Amdipharm Mercury Limited)
    • private equity company Cinven, consisting for the purpose of this case, of Cinven (Luxco 1) S.A., Cinven Capital Management (V) General Partner Limited and Cinven Partners LLP

 


<< Previous
Bullboard Posts
Next >>